Literature DB >> 6036737

The mechanisms underlying the hypolipidaemic effects of atromid S, nicotinic acid and benzalecene. I. The metabolism of free fatty acid-albumin complex by the isolated perfused liver.

M A Mishkel, W F Webb.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1967        PMID： 6036737     DOI： 10.1016/0006-2952(67)90062-7

Source DB:  PubMed          Journal:  Biochem Pharmacol        ISSN： 0006-2952            Impact factor:   5.858


× No keyword cloud information.
  5 in total

1.  Inhibition of hormone-stimulated lipolysis by clofibrate. A possible mechanism for its hypolipidemic action.

Authors:  M A D'Costa; A Angel
Journal:  J Clin Invest       Date:  1975-01       Impact factor: 14.808

2.  Paradoxical effects of clofibrate on liver and muscle metabolism in rats. Induction of myotonia and alteration of fatty acid and glucose oxidation.

Authors:  H S Paul; S A Adibi
Journal:  J Clin Invest       Date:  1979-08       Impact factor: 14.808

3.  Effect of halofenate and clofibrate on growth and lipid synthesis in Saccharomyces cerevisiae.

Authors:  M D Greenspan; J I Germershausen
Journal:  J Bacteriol       Date:  1973-02       Impact factor: 3.490

4.  The fatty acid pattern of triglycerides in liver, adipose tissue and serum of diabetics with hyperlipoproteinemia before and during clofibrate treatment.

Authors:  P Singer; G Gnauck; G Honigmann; H Thoelke
Journal:  Acta Diabetol Lat       Date:  1978 Jan-Apr

5.  Effect of clofibrate on lipoprotein metabolism in hyperlipidemic rats.

Authors:  P Segal; P S Roheim; H A Eder
Journal:  J Clin Invest       Date:  1972-07       Impact factor: 14.808
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.